Skip to main content

Keith Ward

Equibles does not estimate personal net worth.

Get an email with a short summary when Skye Bioscience, Inc. publishes a filing, an earnings call transcript or a press release.

Get SKYE alerts

About Keith Ward

Keith Ward is recorded as Board Member at Skye Bioscience, Inc. (SKYE) since December 14, 2021. Skye Bioscience, Inc. reported in an 8-K filed December 20, 2021 that Keith Ward was appointed director, effective December 14, 2021. Skye Bioscience, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Skye Bioscience, Inc. includes Lisa Anson (CEO), Punit Dhillon (CEO, Chief Accounting Officer and Board Member), Paul Grayson (Chairman and Board Member) and 7 others.

“On December 14, 2021, the Board of Directors (the “Board”) of Skye Bioscience, Inc., a Nevada corporation (the “Company”) increased the size of the Board from four to five directors and elected Dr. Keith Ward, Ph.D. to fill such vacancy and serve as a director until his successor is duly elected or appointed and qualified or until his earlier retirement, disqualification resignation, removal or death.”
Skye Bioscience, Inc. Form 8-K, filed December 20, 2021 · Read the filing

Affiliation history

Company network

Leadership on record at Skye Bioscience, Inc.

Recent activity